Summary: Retatrutide may modestly reduce blood pressure as part of its broader cardiometabolic effects, but it remains an investigational medicine not yet licensed in the UK, and its full cardiovascular profile has not been established
Were excited to work with Lilly to offer the newest GLP-1 pill on the market, said Zach Reitano, co-founder and CEO of Ro, in the announcement
And for those who DO have true GLP-1 resistance, the habits Im going to talk about in this blog will help you overcome this too
However, as more patients begin their journey toward metabolic health, a common question arises during the quiet hours of the afternoon or the morning after an injection: Why am I so tired
I also did their weight loss program and felt heard every ... Dr
This results in an increasing number of clinical trials